Skip to content

Thumb Basal Joint (CMC I) Arthritis - Preoperative Anxiety/Depression, Outcome Instruments, Carpal Cinematics and Cost-utility

Thumb Basal Joint (CMC I) Arthritis - Preoperative Anxiety/Depression, Outcome Instruments, Carpal Kinematics and Cost-utility

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04826380
Enrollment
150
Registered
2021-04-01
Start date
2021-03-29
Completion date
2025-04-01
Last updated
2021-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Arthropathy, Quality of Life, Thumb Osteoarthritis

Brief summary

A project aiming to promote evidence based practice when treating thumb basal joint (CMC I) arthritis. We will aim to: 1) provide the minimal clinical difference of two general outcome instruments, 2) evaluate the association between pre-operative anxiety and/or depression and outcomes following trapeziectomy, 3) evaluate the effect of trapziectomy on carpal cinematics, 4) determine the cost-utility-ratio of trapeziectomy

Interventions

PROCEDURETrapeziectomy

Simple trapeziectomy (without LRTI)

Sponsors

Töölö Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Eaton-Glickel \>2 arhritis * Symptom duration \>3 months * Pain VAS \>30mm * No significant comorbidities, ASA I-II * Fluent in Finnish language

Exclusion criteria

* Eaton-Glickel \<2 * Duration of symptoms \<3 months * VAS \<30mm * ASA \>II * Inflammatory joint disease * Systemic corticosteroid or immunomodulatory medication * Upper limb symptoms not explained with CMC I artritis * Heavy smoking (\> 20 cigarettes per day) * Alcohol or drug abuse * Neurological condition affecting upper limb function * Other ipsilateral upper limb condition requiring surgery

Design outcomes

Primary

MeasureTime frameDescription
Patient-Rated Wrist Evaluation12 monthsThe PRWE comprises 15 questions to measure wrist pain and disability in daily activities. In PRWE patients rate wrist pain and disability from 0 to 10 and it consists two subscales: Pain and Function (0=best possible outcome, 10=worst possible outcome)
Michigan Hand Outcome Questionnaire12 monthsA hand-specific outcomes instrument that contains six distinct scales: (1) overall hand function, (2) activities of daily living, (3) pain, (4) work performance, (5) aesthetics, and (6) patient satisfaction with hand function.

Secondary

MeasureTime frameDescription
Global improvemen12 monthsGlobal rating to treatment effect will be evaluated by question: How would you rate the function of your hand compared to the situation before the treatment?. The options are in 5-step Likert scale from (-2) Much worse to (+2) Much better
Grip strength12 monthsGrip strength is measured with a dynamometer in kg as the mean of three measurements. It will be numbered in kg and percentage of the unaffected side
Wrist and hand (thumb) range of motion (ROM)12 monthsROM is measured on both hands with a handheld goniometer in degrees.
Pain Catastrophizing Scale12 monthsA pain catastrophizing scale comprising of three subscales: (1) Helplessness, (2) Rumination, and (3) Magnification
Carpal Kinematics12 monthsEvaluated from preoperative and compared to 1-year postoperative 4-dimension cone-beam tomography - the wrists are imaged in 7 different postures to reproduce carpal movement, the pre and postoperative scans will be compared to evalueate the effect of trapeziectomy on carpal kinematics (e.g. scapholunate angle, lunotriquetral angle, metacarpal subsidence)
Beck Depression Inventory12 months21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression
Cost-utility12 monthsQuality-adjusted life years/months measured as a change in EQ-5D
Pain (Visual Analogue Scale)12 monthsThe VAS is derived by health care professional question of pain in scale 0 to 10 (0=no pain, 10=worst possible pain)

Countries

Finland

Contacts

Primary ContactSamuli Aspinen, M.D., Ph.D.
samuli.aspinen@hus.fi+358406360546

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026